Cardiac 82rubidium PET/CT: Initial European experience

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 12, 2007, Pages 1965-1972

  Groves, Ashley M ^a   Speechly Dick, Marie Elsya ^b   Dickson, John C ^a   Kayani, Irfan ^a   Endozo, Raymondo ^a   Blanchard, Patty ^a   Shastry, Manu ^a   Prvulovich, Elizabeth ^a   Waddington, Wendy A ^a   Ben Haim, Simona ^a   Bomanji, Jamshed B ^a   McEwan, Jean R ^b   Ell, Peter J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Cardiac PET; Cardiology; Perfusion

Indexed keywords

ADENOSINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RUBIDIUM 82; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; RUBIDIUM;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EXERCISE TEST; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INSTRUMENT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MEDICINE; OBESITY; POSITRON EMISSION TOMOGRAPHY; QUALITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; EUROPE; EVALUATION; HEART LEFT VENTRICLE FUNCTION; IMAGE SUBTRACTION; METHODOLOGY; MIDDLE AGED; PILOT STUDY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; CORONARY VESSELS; EUROPE; HUMANS; MIDDLE AGED; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RUBIDIUM RADIOISOTOPES; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 36749005471     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0537-8     Document Type: Article

References (13)

1. Cuocolo A, Acampa W, Inbriaco M, De Luca N, Iovino GL, Salvatore MG. The many ways to myocardial perfusion imaging. Q J Nucl Med Mol Imaging 2005;49:4-18.
2. Machac J. Cardiac Positron Emission Tomography Imaging. Semin Nucl Med 2005;35:17-36.
3. Di Carli MF, Dorbala S. Integrated PET/CT for cardiac imaging. Q J Nucl Med Mol Imaging 2006;50:44-52.
4. Machac J, Bacharach SL, Bateman TM, Bax JJ, Beanlands R, Bengel F, et al. Quality assurance committee of the american society of nuclear cardiology. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol 2006;13:e121-51.
5. Gould KL, Goldstein RA, Mullani NA, Kirkeeide RL, Wong WH, Tewson TJ, et al. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82. J Am Coll Cardiol 1986;7:775-89.
6. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac imaging committee of the council on clinical cardiology of the American heart association. Circulation 2002;105:539-42.
7. Brown KA, Heller GV, Landin RS, Shaw LJ, Beller GA, Pasquale MJ, et al. Early dipyridamole (99m)Tc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events. Circulation 1999;100:2060-66.
8. Stabin MG, Stubbs JB, Toohey RE. Radiation dose estimates for radiopharmaceuticals-NUREG/CR-6345. Oak Ridge Institute of Science and Education, Oak Ridge, Tennessee; 1996.
9. International Commission on Radiological Protection (1998) Radiation Dose to Patients from radiopharmaceuticals publication 80. Addendum 2 to IRCP 53. Also includes Addendum 1 to IRCP Publication 72. Ann ICRP 28(3):116.
10. Schleipman AR, Castronovo FP Jr, Di Carli MF, Dorbala S. Occupational radiation dose associated with Rb-82 myocardial perfusion positron emission tomography imaging. J Nucl Cardiol 2006;13:378-84.
11. Administration of Radioactive Substances Advisory Committee. Notes for guidance on clinical administration of radiopharmaceuticals and use of sealed sources. Chilton, UK: National Radiological Protection Board; 2006;36.
12. Kaufmann PA, Camici PG. Myocardial blood flow measurement by PET: Technical aspects and clinical applications. J Nucl Med 2005;46:75-86.
13. El Fakhri G, Sitek A, Guerin B, Kijewski MF, Di Carli MF, Moore SC. Quantitative dynamic cardiac 82Rb PET using generalized factor and compartment analyses. J Nucl Med 2005;46:1264-71.